Edition

Articles on Janssen vaccine

Displaying all articles

The long-awaited vaccine is a necessary tool in the fight against the most common respiratory viruses. angelp/iStock via Getty Images Plus

May 10, 2023

FDA’s approval of the world’s first vaccine against RSV will offer a new tool in an old fight – 4 questions answered

Annette Regan, University of San Francisco

The newly approved RSV vaccine could be rolled out by fall 2023, in time for the typical winter surge in RSV infections.

The Lagos State government recently approved some private health facilities to administer COVID-19 vaccines in the state. Olukayode Jaiyeola/NurPhoto via Getty Images

November 18, 2021

How the private sector can boost COVID vaccination in Nigeria

Oyewale Tomori, Nigerian Academy of Science

Properly engaged and monitored, Nigeria’s private sector can do more in COVID vaccination exercise.

People line up at a mass vaccination centre during the COVID-19 pandemic in Mississauga, Ont. THE CANADIAN PRESS/Nathan Denette

May 12, 2021

Public health officials are failing to communicate effectively about AstraZeneca

Sibo Chen, Toronto Metropolitan University

Canadian public health organizations have run into a serious communication problem about the AstraZeneca vaccine. Crisis management and communication theories explain what’s gone wrong.

Top contributors

Oyewale Tomori
Fellow, Nigerian Academy of Science
Annette Regan
Adjunct Associate Professor of Epidemiology, University of California, Los Angeles
Sibo Chen
Associate Professor, School of Professional Communication, Toronto Metropolitan University

Articles on Janssen vaccine

Displaying all articles

Related Topics

Top contributors

Links